Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatotic Liver Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07280143
What this trial is testing

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

Who this might be right for
Breast Cancer SurvivorsColorectal (Colon or Rectal) Cancer SurvivorsMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
University of Bern 200
Not applicableNot Yet RecruitingNCT07640880
What this trial is testing

Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV

Who this might be right for
MASLDHIV (Human Immunodeficiency Virus)
Yinzhong Shen 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06823713
What this trial is testing

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

Who this might be right for
End-stage Liver Disease (ESLD)Cirrhosis, LiverCirrhosis, Decompensated+5 more
Resolution Therapeutics Limited 30
Not applicableNot Yet RecruitingNCT07032311
What this trial is testing

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

Who this might be right for
Type 2 DiabetesLiver Disease
SIPPA Solutions INC 180
Not applicableActive Not RecruitingNCT06662851
What this trial is testing

Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
So Yeon Kim 150
Not applicableLooking for participantsNCT07552727
What this trial is testing

Rehabilitation With Exercise-Based Intervention for Nonalcoholic Chronic Hepatic Esteatosis

Who this might be right for
Metabolic Adaptation to High-Intensity Interval TrainingMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
Universidad San Sebastián 30
Not applicableUnknownNCT06154096
What this trial is testing

Liver Fat and Glucagon Resistance

Who this might be right for
Steatosis of Liver
Imperial College London 20
Not applicableLooking for participantsNCT07476703
What this trial is testing

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Who this might be right for
Coronary Artery DiseaseArterial Stiffness, Blood PressureAORTIC VALVE DISEASES+9 more
Danderyd Hospital 1,400
Early research (Phase 1)Looking for participantsNCT07807059
What this trial is testing

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

Who this might be right for
Overweight/ObesityMetabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH)Type 2 Diabetes Mellitus
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Not applicableLooking for participantsNCT06506513
What this trial is testing

Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60
Not applicableNot Yet RecruitingNCT07305324
What this trial is testing

Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI

Who this might be right for
MASLDFibrosis of Liver
Yale University 40
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableStudy completedNCT07362745
What this trial is testing

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

Who this might be right for
Fatty LiverLiver Transplant; ComplicationsIschaemia Reperfusion Injury of Liver+3 more
Xijing Hospital 300
Not applicableNot Yet RecruitingNCT07730853
What this trial is testing

Isocaloric Navy-Bean Substitution in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Icahn School of Medicine at Mount Sinai 40
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Not applicableNot Yet RecruitingNCT07475962
What this trial is testing

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
Institut de Recherches Cliniques de Montreal 100
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Large-scale testing (Phase 3)Not Yet RecruitingNCT07726693
What this trial is testing

Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial

Who this might be right for
Liver Cirrhosis
University College, London 1,142
Not applicableLooking for participantsNCT07382349
What this trial is testing

Electronic Clinical Decision Support Tools for Steatotic Liver Disease

Who this might be right for
MASLD
Vanderbilt University Medical Center 7,200
Not applicableStudy completedNCT07211113
What this trial is testing

Effects of Long-lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcome

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of Campania Luigi Vanvitelli 87
Next Page
15